Report : North America Pharmaceutical Fluid Handling Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Offering (Equipment and Solution & Services), Tubing (TPE, PVC, and Silicone), Application (Fluid Handling and Management, Fluid Preparation, Integration & Automation, Aseptic Processing, Buffer Management, and Others), Usage [Cough Syrup, Intravenous Products, Complex Active Pharmaceutical Ingredients (APIs), and Others], and End User (Biotechnology Companies, Pharmaceutical & Medical Companies, and Others)

At 4.9% CAGR, the North America Pharmaceutical Fluid Handling Market is speculated to be worth US$ 6,075.94 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the North America pharmaceutical fluid handling market was valued at US$ 4,553.21 million in 2022 and is expected to reach US$ 6,075.94 million by 2028, registering an annual growth rate of 4.9% from 2022 to 2028.  Growing adoption of single-use-systems (SUS) in the pharmaceutical industry and increasing drug production are the critical factors attributed to the market expansion.

In pharmaceutical and biopharmaceutical product manufacturing, contamination prevention is a crucial part of the process. The proper handling and storage of fluids are essential to limit the possibility of contamination. Facility layout helps determine the method used by companies to handle fluid transfer and storage. The growing adoption of single-use systems (SUS) reduces product cross-contamination and eliminates the need for cleaning between batches, hence improving efficiency. The SUSs are made in a cleanroom; they are double bagged, and gamma, ethylene oxide, or x-ray methods are used to ensure a sterile system for every batch. During the development of several pharmaceutical products such as vaccines, monoclonal antibodies, and personalized medicines, SUS is used as it offers a faster, simpler, and less expensive manufacturing process. Due to the rising prevalence of chronic diseases, there is a growing demand for effective drugs and products. Hence, companies are increasingly opting for SUS because it enhances the efficiency of processes and reduces costs related to cleaning, sterilization, and maintenance. In addition, low risk of contamination and low water consumption are a few factors supporting the North America pharmaceutical fluid handling market growth. The North America pharmaceutical fluid handling market growth is also attributed to increased company activities and rapid adoption of various business strategies such as collaborations, partnerships, and product launches. Thus, the increased use of SUS in the production and transfer of sterile fluids is driving the growth of the North America pharmaceutical fluid handling market.

On the contrary, high price of failed clinical trails hurdles the growth of North America pharmaceutical fluid handling market.

Based on offering, the North America pharmaceutical fluid handling market is segmented into equipment & solutions and services. The equipment segment held 85.1% market share in 2022, amassing US$ 3,874.18 million. It is projected to garner US$ 5,122.18 million by 2028 to expand at 4.8% CAGR during 2022–2028.

Based on tubing, the North America pharmaceutical fluid handling market is segmented into TPE, PVC, and silicon. The silicon segment held 55.5% share of the North America pharmaceutical fluid handling market in 2022, amassing US$ 2,527.90 million. It is projected to garner US$ 3,325.45 million by 2028 to expand at 4.7% CAGR during 2022–2028.

Based on application, the North America pharmaceutical fluid handling market is segmented into fluid handling and management, fluid preparation, integration and automation, aseptic processing, buffer management, and others. The fluid handling and management segment held 33.8% share of the North America pharmaceutical fluid handling market in 2022, amassing US$ 1,539.90 million. It is projected to garner US$ 2,018.08 million by 2028 to expand at 4.6% CAGR during 2022–2028.

Based on usage, the North America pharmaceutical fluid handling market is segmented into cough syrup, intravenous products, complex active pharmaceutical ingredients (APIs), and others. The cough syrup segment held 39.8% share of the North America pharmaceutical fluid handling market in 2022, amassing US$ 1,811.36 million. It is projected to garner US$ 2,365.53 million by 2028 to expand at 4.5% CAGR during 2022–2028.

Based on end user, the North America pharmaceutical fluid handling market is segmented into biotechnology companies, pharmaceutical and medical companies, and others. The biotechnology companies segment held 45.9% market share in 2022, amassing US$ 2,087.69 million. It is projected to garner US$ 2,870.53 million by 2028 to expand at 5.5% CAGR during 2022–2028.

Based on country, the North America pharmaceutical fluid handling market is segmented into the US, Canada, and Mexico. Our regional analysis states that the US captured 82.8% market share in 2022. It was assessed at US$ 3,769.60 million in 2022 and is likely to hit US$ 4,990.17 million by 2028, exhibiting a CAGR of 4.8% during the forecast period.

Key players dominating the North America pharmaceutical fluid handling market are CIRCOR International Inc, Danaher Corp, Merck KGaA, Parker Hannifin Corp, RAUMEDIC AG, Rochling SE & Co KG, Spirax Sarco Engineering plc, and Tef Cap Industries Inc, among others.  

  • In 2021, Rigaku Corporation has acquired all issued shares of MILabs B.V.  on August 2, 2021, as part of their full-scale effort to enter the life sciences business. Through this acquisition, Rigaku will expand its life sciences modality business globally by combining MILabs’ multi-modality businesses, including PET, SPECT, Optical Imaging, and CT equipment for animals, with Rigaku's original X-ray imaging business for animals.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com

Download Free PDF Brochure